Pharmacology

Action Mechanism of Action Reference
AGONIST Glucagon-like peptide 1 receptor agonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Smoking Cessation 2 D016540 ClinicalTrials
Polydipsia 2 D059606 ClinicalTrials
Renal Insufficiency, Chronic 2 D051436 ClinicalTrials
Diabetes Mellitus, Type 1 2 D003922 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
19.19
General disorders and administration site conditions
18.86
Injury, poisoning and procedural complications
18.85
Investigations
9.5
Skin and subcutaneous tissue disorders
5.2
Nervous system disorders
4.75
Vascular disorders
4.52
Metabolism and nutrition disorders
3.78
Psychiatric disorders
2.57
Musculoskeletal and connective tissue disorders
2.09
Cardiac disorders
2.02

Cross References

Resources Reference
CAS NUMBER 923950-08-7
ChEMBL CHEMBL2108027
FDA SRS WTT295HSY5
Guide to Pharmacology 7638